Position in KYMR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$88,544,160
+$24,230,538 QoQ
Shares Held
772,165
0.0% QoQ
Ownership
0.929%
of shares outstanding
% of Portfolio
16.82%
of 13F equity value
Holder Rank
#20
of 273 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Merck & Co., Inc. holds $338,204,928 across 12 Biotechnology names. KYMR ranks #2 (26.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
2,308,190 | $161,642,545 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
This page
|
772,165 | $88,544,160 | |
| 3 | AKTS |
Aktis Oncology, Inc.
|
952,844 | $30,710,162 | |
| 4 | EIKN |
Eikon Therapeutics, Inc.
|
1,666,666 | $21,749,991 | |
| 5 | TRDA |
Entrada Therapeutics, Inc.
|
1,739,768 | $12,804,692 | |
| 6 | STRO |
Sutro Biopharma, Inc.
|
272,351 | $9,042,053 | |
| 7 | ALEC |
Alector, Inc.
|
3,545,719 | $7,126,895 | |
| 8 | EVAX |
Evaxion A/S
|
1,214,126 | $3,763,790 |
All Filings in KYMR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,544,160 | 772,165 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $64,313,622 | 772,165 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $60,082,158 | 772,165 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $43,704,539 | 772,165 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $33,697,280 | 772,165 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $21,134,156 | 772,165 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $31,064,197 | 772,165 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||